Vasopressin CPR Trial Community Consultation
Ethical Considerations Associated with Investigator Payments & Patient Recruitment Ginger Clasby - EVP, Business Development Promedica International Costa.
Compliance Considerations in Pharmaceutical Product Development Compliance Considerations in Pharmaceutical Product Development John C. (Jack) Garvey,
FDA Compliance Actions Against IRBs and Clinical Investigators Paul W. Goebel, Jr., CIP Vice President [email protected] Chesapeake Research Review,
Evaluating Minimal Risk: Time to Adopt a Uniform Standard Celia B. Fisher, Ph.D. Marie Ward Doty Professor of Psychology Director Center for Ethics Education.
Legislative Planning for 2008 Medical Society of the State of NY
THE UNIVERSITY OF NEW MEXICO ▪ HEALTH SCIENCES CENTER Clinical and Translational Science Center (CTSC) 4/2009.
Institutional Review Board for Human Subject Research: Does Your Research Need One? Merle Rosenzweig [email protected] [email protected] Michael Unsworth.
AMERICAN CONFERENCE INSTITUTE 12 th National Conference On Managing Legal Risks And Conducting Clinical Trials New York City February 24, 2010 Michael.
UCSF-CDDS 2007 Role of FDA in Guiding Drug Development Carl Peck Center for Drug Development Science UCSF, UC-Washington Center Washington DC Principles.
Radiological Devices Advisory Committee Meeting November 18, 2009 John A. DeLucia iCAD, Inc.
Proposal to Modify Existing or Establish New Requirements for the Informed Consent of Living Donors (Resolution 18) Living Donor Committee Mary Amanda.
